DuPont Launches AmberChrom™ SIL Silica Gel for Chromatography to Advance Manufacturing of GLP-1 and Other Peptide Therapeutics
DuPont launched AmberChrom™ SIL silica gel, a reverse-phase silica chromatography media for purifying peptide therapeutics including GLP-1 receptor agonists. The product, available in C8 and C18 chemistries, expands DuPont's bioprocessing purification portfolio and can be integrated with AmberChrom™ XT and other resins in a single workflow.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.